Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2014

Open Access 01-12-2014 | Case report

Septic shock due to Aeromonas hydrophila bacteremia in a patient with alcoholic liver cirrhosis: a case report

Authors: Tetsuya Yumoto, Shingo Ichiba, Nao Umei, Sunao Morisada, Kohei Tsukahara, Keiji Sato, Toyomu Ugawa, Yoshihito Ujike

Published in: Journal of Medical Case Reports | Issue 1/2014

Login to get access

Abstract

Introduction

Aeromonas hydrophila sometimes causes bacteremia, which can be fatal in compromised patients, such as those with liver cirrhosis. We present a case of septic shock due to Aeromonas hydrophila bacteremia in a patient with liver cirrhosis, which was successfully treated with rapid resuscitation and critical care.

Case presentation

A 71-year-old Japanese man with liver cirrhosis was transported to our emergency center by ambulance after presenting with gait difficulties and fever. On arrival, he exhibited shock and severe lactic acidosis, which was suggestive of sepsis, and was immediately resuscitated and administered empiric antibiotic therapy. He also displayed catecholamine-resistant hypotension, which was successfully treated with critical care including supportive therapies, such as polymyxin B hemoperfusion and cytokine-absorbing hemofiltration. Aeromonas hydrophila was detected in his initial blood cultures.

Conclusions

Aeromonas septicemia should be considered in patients with alcoholic liver cirrhosis who have profound shock. In addition to goal-directed therapy and the prompt administration of empiric antibiotic therapy, aggressive critical care involving multiple supportive therapies can save such patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parker JL, Shaw JG: Aeromonas spp. clinical microbiology and disease. J Infect. 2011, 62: 109-118. 10.1016/j.jinf.2010.12.003.CrossRefPubMed Parker JL, Shaw JG: Aeromonas spp. clinical microbiology and disease. J Infect. 2011, 62: 109-118. 10.1016/j.jinf.2010.12.003.CrossRefPubMed
2.
go back to reference Igbinosa IH, Igumbor EU, Aghdasi F, Tom M, Okoh AI: Emerging Aeromonas species infections and their significance in public health. Sci World J. 2012, 2012: 625023- Igbinosa IH, Igumbor EU, Aghdasi F, Tom M, Okoh AI: Emerging Aeromonas species infections and their significance in public health. Sci World J. 2012, 2012: 625023-
3.
go back to reference Chalermrat B, Disaya C: Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. World J Hepatol. 2012, 4: 158-168. 10.4254/wjh.v4.i5.158.CrossRef Chalermrat B, Disaya C: Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. World J Hepatol. 2012, 4: 158-168. 10.4254/wjh.v4.i5.158.CrossRef
4.
go back to reference Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345: 1368-1377. 10.1056/NEJMoa010307.CrossRefPubMed Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345: 1368-1377. 10.1056/NEJMoa010307.CrossRefPubMed
5.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006, 34: 1589-1596. 10.1097/01.CCM.0000217961.75225.E9.CrossRefPubMed Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006, 34: 1589-1596. 10.1097/01.CCM.0000217961.75225.E9.CrossRefPubMed
6.
go back to reference Ogura H, Gando S, Saitoh D, Takeyama N, Kushimoto S, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Miki Y, Shiraishi S, Suzuki K, Suzuki Y, Takuma K, Tsuruta R, Yamaguchi N, Aikawa N, Japanese Association for Acute Medicine Sepsis Registry (JAAMSR) Study Group: Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother. 2014, 20 (3): 157-162. 10.1016/j.jiac.2013.07.006.CrossRefPubMed Ogura H, Gando S, Saitoh D, Takeyama N, Kushimoto S, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Miki Y, Shiraishi S, Suzuki K, Suzuki Y, Takuma K, Tsuruta R, Yamaguchi N, Aikawa N, Japanese Association for Acute Medicine Sepsis Registry (JAAMSR) Study Group: Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother. 2014, 20 (3): 157-162. 10.1016/j.jiac.2013.07.006.CrossRefPubMed
7.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guideline for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guideline for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41.
8.
go back to reference Gustot T, Felleiter P, Pickkers P, Sakr Y, Rello J, Velissaris D, Pierrakos C, Taccone FS, Sevcik P, Moreno C, Vincent JL, the EPIC II Group of Investigators: Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study. Liver Int. 2014, 10 (1111): 12520- Gustot T, Felleiter P, Pickkers P, Sakr Y, Rello J, Velissaris D, Pierrakos C, Taccone FS, Sevcik P, Moreno C, Vincent JL, the EPIC II Group of Investigators: Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study. Liver Int. 2014, 10 (1111): 12520-
9.
go back to reference Shizuma T, Tanaka C, Mori H, Fukuyama N: Investigation of bacteremia due to Aeromonas species and comparison with that due to enterobacteria in patients with liver cirrhosis. Gastroenterol Res Pract. 2011, 2011: 930826-CrossRefPubMedPubMedCentral Shizuma T, Tanaka C, Mori H, Fukuyama N: Investigation of bacteremia due to Aeromonas species and comparison with that due to enterobacteria in patients with liver cirrhosis. Gastroenterol Res Pract. 2011, 2011: 930826-CrossRefPubMedPubMedCentral
10.
go back to reference Choi JP, Lee SO, Kwon HH, Kwak YG, Choi SH, Lim SK, Kim MN, Jeong JY, Choi SH, Woo JH, Kim YS: Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study. Clin Infect Dis. 2008, 47: 66-72. 10.1086/588665.CrossRefPubMed Choi JP, Lee SO, Kwon HH, Kwak YG, Choi SH, Lim SK, Kim MN, Jeong JY, Choi SH, Woo JH, Kim YS: Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study. Clin Infect Dis. 2008, 47: 66-72. 10.1086/588665.CrossRefPubMed
11.
go back to reference Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, Kline JA, Jones AE, Emergency Medicine Shock Research Network (EMSHOCKNET): Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011, 39: 2066-2071. 10.1097/CCM.0b013e31821e87ab.CrossRefPubMedPubMedCentral Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, Kline JA, Jones AE, Emergency Medicine Shock Research Network (EMSHOCKNET): Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011, 39: 2066-2071. 10.1097/CCM.0b013e31821e87ab.CrossRefPubMedPubMedCentral
12.
go back to reference Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, Lentini P, Nalesso F, Ueno T, Ranieri VM, Ronco C: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007, 22: R47-CrossRef Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, Lentini P, Nalesso F, Ueno T, Ranieri VM, Ronco C: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007, 22: R47-CrossRef
13.
go back to reference Oda S, Sadahiro T, Hirayama Y, Nakamura M, Watanabe E, Tateishi Y, Hirasawa H: Non-renal indications for continuous renal replacement therapy: current status in Japan. Contrib Nephrol. 2010, 166: 47-53.CrossRefPubMed Oda S, Sadahiro T, Hirayama Y, Nakamura M, Watanabe E, Tateishi Y, Hirasawa H: Non-renal indications for continuous renal replacement therapy: current status in Japan. Contrib Nephrol. 2010, 166: 47-53.CrossRefPubMed
14.
go back to reference Yamakawa K, Fujimi S, Mohri T, Matsuda H, Nakamori Y, Hirose T, Tasaki O, Ogura H, Kuwagata Y, Hamasaki T, Shimazu T: Treatment of effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study. Crit Care. 2011, 15: R123-10.1186/cc10228.CrossRefPubMedPubMedCentral Yamakawa K, Fujimi S, Mohri T, Matsuda H, Nakamori Y, Hirose T, Tasaki O, Ogura H, Kuwagata Y, Hamasaki T, Shimazu T: Treatment of effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study. Crit Care. 2011, 15: R123-10.1186/cc10228.CrossRefPubMedPubMedCentral
Metadata
Title
Septic shock due to Aeromonas hydrophila bacteremia in a patient with alcoholic liver cirrhosis: a case report
Authors
Tetsuya Yumoto
Shingo Ichiba
Nao Umei
Sunao Morisada
Kohei Tsukahara
Keiji Sato
Toyomu Ugawa
Yoshihito Ujike
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2014
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-8-402

Other articles of this Issue 1/2014

Journal of Medical Case Reports 1/2014 Go to the issue